Sort
82,697 grants matching “vaccine development”
AIDS CLINICAL TRIALS UNIT
$1,921,768Stanford University · U01 · FY2001 · AI
New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS)
$1,920,723Elihu Estey · University Of Tx Md Anderson Can Ctr · P01 · FY2006 · CA
Tulane University COVID Antibody and Immunity Network (TUCAIN)
$1,920,358James E Robinson · Tulane University Of Louisiana · U54 · FY2022 · CA
Role of the microbiota in immunity
$1,920,053Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Papillomavirus Virion Proteins and Vaccines
$1,919,421John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
NONHUMAN PRIMATE (NHP) CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH DEVELOPMENT
$1,919,075Amitinder Kaur · Tulane University Of Louisiana · N01 · FY2019 · AI
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
$1,918,695Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Mechanisms of broadly neutralizing humoral immunity against influenza viruses
$1,918,351Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2016 · AI
Mechanisms of broadly neutralizing humoral immunity against influenza viruses
$1,918,351Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI
Mechanisms of broadly neutralizing humoral immunity against influenza viruses
$1,918,351Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2018 · AI
Mechanisms of broadly neutralizing humoral immunity against influenza viruses
$1,918,351Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2017 · AI
New Approaches to the Biology and Treatment of Myelodysplastic Syndromes (MDS)
$1,917,919Elihu Estey · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
Nonhuman Primate (NHP) Core Cellular Immunology Laboratory for AIDS Vaccine Research Development
$1,917,608Amitinder Kaur · Tulane University Of Louisiana · N01 · FY2023 · AI
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
$1,917,582Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2012 · CA
CD40L adjuvanted clade C DNA and MVA HIV vaccines
$1,917,505Rama Rao Amara · Emory University · U19 · FY2017 · AI
Emory/Atlanta Center for AIDS Research
$1,917,457James W. Curran · Emory University · P30 · FY2009 · AI
Vanderbilt HIV Clinical Trials Unit
$1,917,163David W Haas · Vanderbilt University · UM1 · FY2012 · AI
Host-Tumor Cell Interactions in Myeloma Therapeutic Appl
$1,917,010Dana-Farber Cancer Institute · P01 · FY2003 · CA
Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis
$1,916,780Matthew Adrian Coleman · Lawrence Livermore National Security, Llc · U19 · FY2022 · AI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$1,916,770Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
HIV VACCINES TRIAL UNITS
$1,916,713Fred Hutchinson Cancer Research Center · U01 · FY2001 · AI
Administration
$1,916,668Ronald B Corley · Boston University Medical Campus · UC7 · FY2021 · AI
Core 5: Integrated Support Services
$1,916,667Ronald B Corley · Boston University Medical Campus · UC7 · FY2021 · AI
Seattle-Lausanne-Kampala CTU
$1,916,595Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · AI
Enhancing T Cell Therapy of Cancer
$1,916,364Helen E Heslop · Baylor College Of Medicine · P01 · FY2012 · CA